首页>
外文OA文献
>Efeitos dos compostos quercetina, quercetina em nanoemulsão, resveratrol e rutina sobre a hepatotoxicidade e neurotoxicidade induzidas por oxaliplatina em camundongos
【2h】
Efeitos dos compostos quercetina, quercetina em nanoemulsão, resveratrol e rutina sobre a hepatotoxicidade e neurotoxicidade induzidas por oxaliplatina em camundongos
Introduction : Oxaliplatin is an antineoplastic agent widely used in the treatment of some tumors. It is a third-generation platinum compound developed with the purpose of overcoming the limitations of toxicity, tumor resistance and poor oral bioavailability associated to cisplatin administration. Oxaliplatin-associated neurotoxicity represents the main dose limiting and there is not suitable treatment. Increasing doses of oxaliplatin can leed to the development of mechanical allodynia, cold sensitivity and peripheral sensory neuropathy, with increase of symptoms. Furthermore, despite its usefulness, chemotherapy with oxaliplatin increases the rate of developing hepatic damages together with inflammatory activity. This might be termed chemotherapy-associated steatohepatitis (CASH), a most severe form of non-alcoholic fatty liver disease. Therefore, in the presentstudy, we aimed to compare the effect of antioxidant compounds on simultaneous development of oxaliplatin-induced hepato and neurotoxicity in mice. Methods : The Balb/c mice were treated with doses of oxaliplatin (OXA) for 6 weeks, 10 mg/kg, intraperitoneally (i. p), resulting in mechanical allodynia, and hepatic steatosis. We administered antioxidants compounds such as rutin (RUT) (20 mg/Kg/d), resveratrol (RVS) (100 mg/Kg/d), quercetin (QT) (20 mg/Kg/d) and nanoquerecetin (NQT) (20 mg/Kg/d) daily by gavageto Balb/c. N-acetyl-cysteine was used as control. Euthanasiaoccurred onday 43after treatment. We evaluated mechanical nociceptive threshold, ALT/AST, histopathological analysisand MPOactivity. Statistical analyses were made one way ANOVA, followed by Bonferroni post hoc test. Results : The treatments with RSV, RUT or NQT were able to prevent mechanical allodynia when compared to OXA group. Regarding the effect on steatohepatitis, resveratrol, quercetin and quercetin nanoemulsion almost completely reversed the mean liver weight increase by OXA. In accordance with these previous data, histological evaluation depicted attenuation all features of hepatic steatosis evaluated in resveratrol, rutin, quercetin and quercetin nanoemulsion groups. On the other hand, only quercetin and quercetin nanoemulsion treatments were able to reduce neutrophils migration measured by MPO activity. Conclusion : These results suggest that the use of compounds such as resveratrol, rutin, quercetin and quercetin nanoemulsion can beeffective to avoid oxaliplatin-inducing hepato and neurotoxicity in a rodent model.
展开▼
机译:简介:奥沙利铂是一种抗肿瘤药,广泛用于治疗某些肿瘤。它是第三代铂化合物,旨在克服与顺铂给药相关的毒性,肿瘤耐受性和不良的口服生物利用度的局限性。奥沙利铂相关的神经毒性代表主要剂量限制,尚无合适的治疗方法。奥沙利铂剂量的增加可导致机械性异常性疼痛,感冒和周围感觉神经病的发展,并伴有症状增加。此外,尽管有用,用奥沙利铂的化学疗法增加了发生肝损害的速率以及炎性活性。这可能被称为化疗相关性脂肪性肝炎(CASH),这是最严重的非酒精性脂肪肝疾病。因此,在本研究中,我们旨在比较抗氧化剂化合物对奥沙利铂诱导的肝细胞同时发育和小鼠神经毒性的影响。方法:对Balb / c小鼠进行腹腔内(i。p)剂量的奥沙利铂(OXA)治疗6周,剂量为10 mg / kg,持续6周,导致机械性异常性疼痛和肝脂肪变性。我们施用了抗氧化剂化合物,例如芦丁(RUT)(20 mg / Kg / d),白藜芦醇(RVS)(100 mg / Kg / d),槲皮素(QT)(20 mg / Kg / d)和纳米槲皮素(NQT)(每天20毫克/千克/天)通过灌胃法制取Balb / c。 N-乙酰基半胱氨酸用作对照。治疗后第43天发生了安乐死。我们评估了机械伤害阈值,ALT / AST,组织病理学分析和MPO活性。统计分析是一种方差分析,然后进行Bonferroni事后检验。结果:与OXA组相比,采用RSV,RUT或NQT的治疗能够预防机械性异常性疼痛。关于对脂肪性肝炎的影响,白藜芦醇,槲皮素和槲皮素纳米乳剂几乎完全抵消了OXA引起的平均肝脏重量增加。根据这些先前的数据,组织学评估显示减弱了白藜芦醇,芦丁,槲皮素和槲皮素纳米乳剂组中肝脂肪变性的所有特征。另一方面,只有槲皮素和槲皮素纳米乳剂处理能够减少通过MPO活性测得的中性粒细胞迁移。结论:这些结果表明,在啮齿动物模型中,使用白藜芦醇,芦丁,槲皮素和槲皮素纳米乳等化合物可有效避免奥沙利铂诱导的肝和神经毒性。
展开▼